Rx|X specializes in comprehensive compliance reviews, independent audits, policy analysis and reports, and litigation support for stakeholders in the 340B Drug Discount Program.
Our 16 years of direct experience with this pharmaceutical program places Rx|X in a unique position to offer perspective, a proper assessment of potential issues, and sound advice. We offer high quality research, analytics, and consulting services based on our senior level experience with the Office of Inspector General and through our ongoing engagements with federal and state governments, 340B covered entities, law firms and advocacy organizations. This broad and varied experience gives us a distinct advantage in understanding all relevant issues and offering tailored and pragmatic solutions for our clients.
(click on the box for more information)